- Home
- CHKP vs SNN Comparison
CHKP vs SNN Comparison
Compare CHKP & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CHKP | SNN |
|---|---|---|
| Founded | 1993 | 1856 |
| Country | Israel | United Kingdom |
| Employees | N/A | 16988 |
| Industry | Computer Software: Prepackaged Software | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.1B | 14.3B |
| IPO Year | 1997 | N/A |
Fundamental Metrics
Financial Performance| Metric | CHKP | SNN |
|---|---|---|
| Price | $123.19 | $30.14 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 20 | 2 |
| Target Price | ★ $199.50 | $36.25 |
| AVG Volume (30 Days) | ★ 1.2M | 1.1M |
| Earning Date | 04-30-2026 | 03-16-2026 |
| Dividend Yield | N/A | ★ 2.48% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.31 | $8.58 |
| Revenue Next Year | $6.03 | $5.60 |
| P/E Ratio | ★ $17.05 | $64.97 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $112.23 | $28.79 |
| 52 Week High | $225.23 | $38.79 |
Technical Indicators
Market Signals| Indicator | CHKP | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 41.62 | 44.59 |
| Support Level | $112.29 | $29.10 |
| Resistance Level | $141.31 | $31.28 |
| Average True Range (ATR) | 4.63 | 0.49 |
| MACD | -1.08 | 0.03 |
| Stochastic Oscillator | 23.98 | 41.67 |
Price Performance
Historical ComparisonAbout CHKP Check Point Software Technologies Ltd.
Check Point Software Technologies is a pure-play cybersecurity vendor. The company offers solutions for network, endpoint, cloud, and mobile security in addition to security management. Check Point, a software specialist, sells to enterprises, businesses, and consumers. Around 50% of revenue is generated in Europe, the Middle East, and Africa, 40% from the Americas, and 10% from the Asia-Pacific region. The firm, based in Tel Aviv, Israel, was founded in 1993 and has about 5,000 employees.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.